» Articles » PMID: 21656179

Efficacy and Tolerability of Split-dose PEG Compared with Split-dose Aqueous Sodium Phosphate for Outpatient Colonoscopy: a Randomized, Controlled Trial

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2011 Jun 10
PMID 21656179
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Adequate bowel cleansing is essential for a high-quality, effective, and safe colonoscopy. The aims of this study were to compare the efficacy and tolerability of split-dose polyethylene glycol with aqueous sodium phosphate for outpatients who underwent scheduled colonoscopy.

Methods: In this prospective trial, 207 outpatients (aged between 18 and 65 years, with normal renal function, at low risk for renal damage) were randomized to receive split-dose preparation of PEG (2 L/2 L) (N = 103) or NaP (45 mL/45 mL, 12 h apart) (N = 104) without strict diet restriction the day before colonoscopy. The bowel cleansing efficacy of preparations was rated according to the Ottawa scale and the patient tolerability was assessed using a patient questionnaire.

Results: There was no significant difference between the two groups for the mean total score using the Ottawa bowel preparation scale (P = 0.181). Significantly greater residual colonic fluid was observed in the split-dose PEG group (1.24 ± 0.49) than in the NaP group (1.04 ± 0.53) (P = 0.007). Patient compliance, preference, and acceptance of a two preparation regimen were similar with no significant differences (P = 0.095, P = 0.280 and P = 0.408, respectively). The overall incidence of adverse events was not significantly different between the two groups; however, the split-dose PEG group tended to have fewer adverse events (52/103 [50.5%], 66/104 [63.5%], P = 0.059) and had significantly less nausea and vomiting (P = 0.036).

Conclusions: Split-dose PEG, compared with split-dose NaP, is associated with more residual colonic fluid, but produces equivalent colon cleansing efficacy and results in less nausea and vomiting, which might improve patient tolerability (clinical trial registration number NCT01229800).

Citing Articles

Predictive Model of Functional Exercise Compliance of Patients with Breast Cancer Based on Decision Tree.

Luo Z, Luo B, Wang P, Wu J, Chen C, Guo Z Int J Womens Health. 2023; 15:397-410.

PMID: 36974132 PMC: 10039631. DOI: 10.2147/IJWH.S386405.


Electrolyte disturbances after bowel preparation for colonoscopy: Systematic review and meta-analysis.

Reumkens A, van der Zander Q, Winkens B, Bogie R, Bakker C, Sanduleanu S Dig Endosc. 2022; 34(5):913-926.

PMID: 35037327 PMC: 9543544. DOI: 10.1111/den.14237.


Effect of an intensive patient educational programme on the quality of bowel preparation for colonoscopy: a single-blind randomised controlled trial.

Janahiraman S, Tay C, Lee J, Lim W, Khiew C, Ishak I BMJ Open Gastroenterol. 2020; 7(1).

PMID: 32371502 PMC: 7228661. DOI: 10.1136/bmjgast-2020-000376.


Sodium phosphate versus polyethylene glycol for colonoscopy bowel preparation: an updated meta-analysis of randomized controlled trials.

Cheng J, Tao K, Shuai X, Gao J Surg Endosc. 2015; 30(9):4033-41.

PMID: 26679172 DOI: 10.1007/s00464-015-4716-6.


Comparison of the Efficacy and Tolerability between Same-day Picosulfate and Split-dose Polyethylene Glycol Bowel Preparation for Afternoon Colonoscopy: A Prospective, Randomized, Investigator-blinded Trial.

Kang M, Kim T, Seo E, Jung D, Kim M, Heo N Intest Res. 2014; 12(1):53-9.

PMID: 25349564 PMC: 4204690. DOI: 10.5217/ir.2014.12.1.53.


References
1.
Abdul-Baki H, Hashash J, Elhajj I, Azar C, El Zahabi L, Mourad F . A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. Gastrointest Endosc. 2008; 68(2):294-300. DOI: 10.1016/j.gie.2008.01.044. View

2.
Vanner S, MacDonald P, Paterson W, Prentice R, Da Costa L, Beck I . A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol. 1990; 85(4):422-7. View

3.
Hookey L, Depew W, Vanner S . The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc. 2002; 56(6):895-902. DOI: 10.1067/mge.2002.129522. View

4.
Markowitz G, Nasr S, Klein P, Anderson H, Stack J, Alterman L . Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol. 2004; 35(6):675-84. DOI: 10.1016/j.humpath.2003.12.005. View

5.
Ell C, Fischbach W, Keller R, Dehe M, Mayer G, Schneider B . A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy. 2003; 35(4):300-4. DOI: 10.1055/s-2003-38150. View